Literature DB >> 731809

Suprapubic prostatectomy. The removable purse string: a continuing comparative analysis of 300 consecutive cases.

G A Nicoll, G N Riffle, F O Andersen.   

Abstract

Mortality rates, length of hospitalization, transfusion requirements, weights of excised tissue, complications and operating time are analyzed in this series of 300 patients who underwent suprapubic prostatectomies in which a removable purse-string closure of the bladder neck was used. The results are compared to those in other studies. The mortality rate in our study is the lowest reported to date for a large series. We believe that this technically simple operation, which has the most adaptability for combination with conjunctive operations, low transfusion requirements, few long-term complications and which can be done rapidly, is the most desirable method to remove benign prostates of 40 gm. or larger. We believe that there should be acceptance of broader indications for its use and that greater emphasis should be placed on teaching this procedure in urological training programs.

Entities:  

Mesh:

Year:  1978        PMID: 731809     DOI: 10.1016/s0022-5347(17)57335-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  A new technique of haemostasis following transvesical prostatectomy.

Authors:  Z Jasiński; Z Wolski
Journal:  Int Urol Nephrol       Date:  1985       Impact factor: 2.370

2.  Volume determinations by transrectal ultrasonography in patients with benign prostatic hyperplasia: correlation with removed prostate weight.

Authors:  I Alkan; L Türkeri; T Biren; I Cevik; A Akdaş
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

3.  Malament stitch and increased risk of bladder neck stenosis: any association following open prostatectomy in Enugu Southeast Nigeria.

Authors:  Okwudili Calistus Amu; Emmanuel Azubuike Affusim; Ugochukwu Uzodimma Nnadozie; Okezie Mbadiwe
Journal:  BMC Urol       Date:  2022-01-13       Impact factor: 2.264

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.